Presbyopia News

Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta.

INDIANAPOLIS — Individuals with mild to moderate presbyopia who were treated with CSF-1 were able to achieve and maintain functional vision for at least 5 hours after two doses, according to a presenter at Academy 2024.

INDIANAPOLIS — High-energy visible light-filtering multifocal lenses reduced glare disability and discomfort without affecting color perception, according to research presented at Academy 2024.

INDIANAPOLIS — An aceclidine-based miotic may improve both near and distance vision in presbyopic patients as a result of its pupil selectivity, according to research presented at Academy 2024.

A catenary curve-based, extended depth of focus multifocal contact lens provided full functional vision range, under naturally varying conditions, for older adults with advanced presbyopia, according to a study in Clinical Ophthalmology.

October is Contact Lens Safety Month, a time to educate the public about proper use and care of both prescription and cosmetic contact lenses, according to Prevent Blindness.

LENZ Therapeutics has submitted a new drug application to the FDA for LNZ100, a preservative-free, once-daily aceclidine-based ophthalmic solution designed to treat presbyopia, the company announced in a press release.

CooperVision has announced the U.S. launch of its new Clariti 1 Day Multifocal 3 Add contact lenses, designed to provide all-day comfort, ease of fit and optimal visual acuity at all distances for all levels of presbyopia.

NASHVILLE, Tenn. — Successful multifocal contact lens fitting starts with a good refraction, an industry executive said here at Optometry’s Meeting.